Genome-Wide Significant Association of the GM 23 Allotype with gp120-Specific IgG2 Titers in an Efficacy Trial of AIDSVAX B/B
Publication
, Conference
Cirulli, ET; Forthal, D; Shianna, KV; Pandey, J; Sinangil, F; Fellay, J; Perez, K; Landucci, G; Tomaras, G; Haynes, BF; Goldstein, DB
Published in: AIDS RESEARCH AND HUMAN RETROVIRUSES
October 1, 2010
Duke Scholars
Published In
AIDS RESEARCH AND HUMAN RETROVIRUSES
ISSN
0889-2229
Publication Date
October 1, 2010
Volume
26
Issue
10
Start / End Page
A70 / A70
Location
Atlanta, GA
Publisher
MARY ANN LIEBERT INC
Conference Name
AIDS Vaccine 2010
Related Subject Headings
- Virology
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Cirulli, E. T., Forthal, D., Shianna, K. V., Pandey, J., Sinangil, F., Fellay, J., … Goldstein, D. B. (2010). Genome-Wide Significant Association of the GM 23 Allotype with gp120-Specific IgG2 Titers in an Efficacy Trial of AIDSVAX B/B. In AIDS RESEARCH AND HUMAN RETROVIRUSES (Vol. 26, pp. A70–A70). Atlanta, GA: MARY ANN LIEBERT INC.
Cirulli, E. T., D. Forthal, K. V. Shianna, J. Pandey, F. Sinangil, J. Fellay, K. Perez, et al. “Genome-Wide Significant Association of the GM 23 Allotype with gp120-Specific IgG2 Titers in an Efficacy Trial of AIDSVAX B/B.” In AIDS RESEARCH AND HUMAN RETROVIRUSES, 26:A70–A70. MARY ANN LIEBERT INC, 2010.
Cirulli ET, Forthal D, Shianna KV, Pandey J, Sinangil F, Fellay J, et al. Genome-Wide Significant Association of the GM 23 Allotype with gp120-Specific IgG2 Titers in an Efficacy Trial of AIDSVAX B/B. In: AIDS RESEARCH AND HUMAN RETROVIRUSES. MARY ANN LIEBERT INC; 2010. p. A70–A70.
Cirulli, E. T., et al. “Genome-Wide Significant Association of the GM 23 Allotype with gp120-Specific IgG2 Titers in an Efficacy Trial of AIDSVAX B/B.” AIDS RESEARCH AND HUMAN RETROVIRUSES, vol. 26, no. 10, MARY ANN LIEBERT INC, 2010, pp. A70–A70.
Cirulli ET, Forthal D, Shianna KV, Pandey J, Sinangil F, Fellay J, Perez K, Landucci G, Tomaras G, Haynes BF, Goldstein DB. Genome-Wide Significant Association of the GM 23 Allotype with gp120-Specific IgG2 Titers in an Efficacy Trial of AIDSVAX B/B. AIDS RESEARCH AND HUMAN RETROVIRUSES. MARY ANN LIEBERT INC; 2010. p. A70–A70.
Published In
AIDS RESEARCH AND HUMAN RETROVIRUSES
ISSN
0889-2229
Publication Date
October 1, 2010
Volume
26
Issue
10
Start / End Page
A70 / A70
Location
Atlanta, GA
Publisher
MARY ANN LIEBERT INC
Conference Name
AIDS Vaccine 2010
Related Subject Headings
- Virology
- 3202 Clinical sciences
- 1103 Clinical Sciences